Ações do setor de saúde
| # | Nome | Preços | 24h % | 7d % | 1M % | 1A % | Capitalização de mercado | Últimos 7 dias | |
|---|---|---|---|---|---|---|---|---|---|
| 141 |  APLS Apellis Pharmaceuticals, Inc. Common Stock | 40.84 USD | +0.12% | +0.57% | +113.82% | +108.15% | 5.22 B USD | ||
| 142 |  IMVT Immunovant, Inc. Common Stock | 25.1200 USD | +2.53% | +1.37% | +1.91% | +30.77% | 5.11 B USD | ||
| 143 |  ERAS Erasca, Inc. Common Stock | 16.31 USD | -4.12% | -3.78% | +15.27% | +1236.89% | 5.07 B USD | ||
| 144 |  SYRE Spyre Therapeutics, Inc. Common Stock | 63.2700 USD | +23.36% | +29.20% | +55.34% | +164.62% | 4.97 B USD | ||
| 145 |  XENE Xenon Pharmaceuticals Inc | 58.6000 USD | +0.34% | +3.37% | +6.43% | +43.66% | 4.87 B USD | ||
| 146 |  APGE Apogee Therapeutics, Inc. Common Stock | 86.7400 USD | +0.54% | +3.59% | +20.46% | +61.86% | 4.86 B USD | ||
| 147 |  CORT Corcept Therapeutics Inc. | 43.3000 USD | +3.32% | +7.28% | +33.81% | -40.98% | 4.61 B USD | ||
| 148 |  OSCR Oscar Health, Inc. | 15.38 USD | +6.36% | +17.67% | +15.21% | +20.06% | 4.58 B USD | ||
| 149 |  FOLD Amicus Therapeutics, Inc | 14.4600 USD | 0.00% | +0.07% | +0.63% | +66.97% | 4.54 B USD | ||
| 150 |  OPCH Option Care Health, Inc. Common Stock | 28.9300 USD | -0.24% | +4.06% | -1.93% | +3.54% | 4.53 B USD | ||
| 151 |  SHC Sotera Health Company Common Stock | 15.7000 USD | +2.21% | +5.94% | +16.56% | -6.88% | 4.46 B USD | ||
| 152 |  NVST Envista Holdings Corporation Common stock, $0.01 par value per share | 26.8150 USD | +1.57% | +4.46% | +7.32% | +30.04% | 4.39 B USD | ||
| 153 |  RDNT RadNet, Inc. Common Stock | 56.2300 USD | +1.44% | +2.27% | -10.42% | -32.59% | 4.36 B USD | ||
| 154 |  ALHC Alignment Healthcare, Inc. Common Stock | 20.9800 USD | +2.34% | +3.55% | +22.33% | +19.82% | 4.29 B USD | ||
| 155 |  LGND Ligand Pharmaceuticals Inc. | 213.4400 USD | +4.16% | +5.10% | +4.47% | +14.07% | 4.26 B USD | ||
| 156 |  MMSI Merit Medical Systems Inc | 70.5700 USD | +3.38% | +4.77% | +0.10% | -14.69% | 4.19 B USD | ||
| 157 |  DOCS Doximity, Inc. | 22.68 USD | +7.79% | -1.69% | -5.50% | -58.12% | 4.19 B USD | ||
| 158 |  NAMS NewAmsterdam Pharma Company N.V. Ordinary Shares | 36.2500 USD | +4.29% | +7.33% | +24.96% | -0.06% | 4.17 B USD | ||
| 159 |  STVN Stevanato Group S.p.A. | 13.74 USD | +1.33% | +1.03% | -10.78% | -34.88% | 4.16 B USD | ||
| 160 |  NNNN Anbio Biotechnology Class A Ordinary Shares | 28.54 USD | +5.31% | +10.62% | +35.71% | +7.94% | 4.06 B USD |
Notícias Ações do setor de saúde
Ações da Cellectis mantêm classificação de desempenho superior com base na plataforma alogênica
Harrow: Probably A Short-Term Market Overreaction (NASDAQ:HROW)
US stock futures climb as traders cling to de-escalation hopes, await earnings
Company News for Apr 14, 2026
Asgard Therapeutics nomeia Wolfram Brugger como diretor médico
Grainger nomeia Fiona Muldoon como diretora não executiva
Allogene Therapeutics, Inc. (ALLO) Discusses Interim Futility Analysis from Pivotal Phase II ALPHA 3 Trial in First-Line Consolidation Large B-Cell Lymphoma - Slideshow (NASDAQ:ALLO) 2026-04-14
Gainers Ações do setor de saúde
 QNCX Quince Therapeutics, Inc. Common Stock | 1.41 | +907.14% |
 AKAN Akanda Corp. Common Shares | 3.01 | +377.78% |
 RVMDW Revolution Medicines, Inc. Common Stock | 4.4100 | +123.86% |
 NRXPW NRX Pharmaceuticals, Inc. Common Stock | 0.0120 | +87.50% |
 VRAX Virax Biolabs Group Limited Ordinary Shares | 0.17 | +70.00% |
 RVMD Revolution Medicines, Inc. Common Stock | 136.3000 | +41.35% |
 GCTK GlucoTrack, Inc. Common Stock | 0.8780 | +32.11% |
 HURA TuHURA Biosciences, Inc. Common Stock | 2.87 | +26.43% |
Losers Ações do setor de saúde
 REPL Replimune Group, Inc. | 1.70 | -64.29% |
 WORX SC WORX Corp | 1.06 | -30.72% |
 ONCO Onconetix, Inc. Common Stock | 0.8000 | -26.61% |
 XAIR Beyond Air, Inc. Common Stock | 0.63 | -18.18% |
 QSIAW Quantum-Si Incorporated Class A Common Stock | 0.0900 | -17.20% |
 ZNTL Zentalis Pharmaceuticals, Inc. Common Stock | 5.56 | -15.89% |
 CLGN CollPlant Biotechnologies Ltd Ordinary Shares | 0.32 | -15.79% |
 BFRIW Biofrontera Inc. Common Stock | 0.0400 | -15.61% |